Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza

NCT02612922 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

325

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

DRUG: Nitazoxanide
DRUG: Placebo

Sponsor

Romark Laboratories L.C.